Matches in Wikidata for { <http://www.wikidata.org/entity/Q64796196> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q64796196 description "clinical trial" @default.
- Q64796196 description "ensayu clínicu" @default.
- Q64796196 description "klinisch onderzoek" @default.
- Q64796196 description "клінічне випробування" @default.
- Q64796196 name "Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer" @default.
- Q64796196 type Item @default.
- Q64796196 label "Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer" @default.
- Q64796196 prefLabel "Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer" @default.
- Q64796196 P1050 Q64796196-462AFBDF-DADA-4DD5-BF9C-04BA7A907F83 @default.
- Q64796196 P1050 Q64796196-4EFFF80D-4620-4F5E-8EF3-D38B2C83934D @default.
- Q64796196 P1132 Q64796196-37B0F095-C75A-40AC-BC8A-E75A133B17DC @default.
- Q64796196 P1476 Q64796196-0D873FF1-BC3B-4E7C-9D0B-2442EB9B5977 @default.
- Q64796196 P17 Q64796196-612D7937-E0ED-4235-BF77-8668199DE7B4 @default.
- Q64796196 P2899 Q64796196-29227271-3B7B-4E56-83AF-61FD60134A0E @default.
- Q64796196 P3098 Q64796196-10A8EAAB-1402-4E46-BFDC-E5C475C1EE50 @default.
- Q64796196 P31 Q64796196-4BCB64A5-9116-45EA-9D37-6B205F606283 @default.
- Q64796196 P4844 Q64796196-E99FCA6A-34D5-4C3C-AE1F-1313828B5C3D @default.
- Q64796196 P580 Q64796196-103C8EE8-E84D-4C28-A1DC-FDB6EE8BC698 @default.
- Q64796196 P582 Q64796196-D262857A-55DF-4E8C-B04B-CE93FD7B4275 @default.
- Q64796196 P6099 Q64796196-38C8B3C4-BC88-42B3-9049-606C0248B1FC @default.
- Q64796196 P6153 Q64796196-799EFF35-EF66-4E65-A07C-9D3A91E1C084 @default.
- Q64796196 P8363 Q64796196-9686A0DA-17AB-44D1-AA9B-FEC0CA55C6B5 @default.
- Q64796196 P1050 Q33525 @default.
- Q64796196 P1050 Q5038170 @default.
- Q64796196 P1132 "+42" @default.
- Q64796196 P1476 "Phase I Study of Mirvetuximab Soravtansine (IMGN853) and Rucaparib for Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer" @default.
- Q64796196 P17 Q30 @default.
- Q64796196 P2899 "+18" @default.
- Q64796196 P3098 "NCT03552471" @default.
- Q64796196 P31 Q30612 @default.
- Q64796196 P4844 Q7376558 @default.
- Q64796196 P580 "2018-07-12T00:00:00Z" @default.
- Q64796196 P582 "2021-08-29T00:00:00Z" @default.
- Q64796196 P6099 Q5452194 @default.
- Q64796196 P6153 Q309331 @default.
- Q64796196 P8363 Q78089383 @default.